DAFNA Capital Management’s EnteroMedics Inc. ETRM Stock Holding History

DAFNA Capital Management’s Portfolio ETRM Stock Details ETRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-476	Closed	-$5K	–	85
2016 Q3	$5K	Hold	476	–	–	﹤0.01%	74
2016 Q2	$10K	Hold	476	–	–	0.01%	91
2016 Q1	$32K	Hold	476	–	–	0.03%	92
2015 Q4	$65K	Hold	476	–	–	0.06%	74
2015 Q3	$130K	Buy	+476	New	+$152K	0.13%	77

Other funds holding ETRM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Cutler Group San Francisco, California $307M AUM 45.11% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

DAFNA Capital Management's ETRM Position: Q4 2016 in Review

DAFNA Capital Management sold out of EnteroMedics Inc. (ETRM) in Q4 2016, closing a stake of 476 shares — an estimated $5K sold.

DAFNA Capital Management first reported a position in ETRM in Q3 2015 and held it in 5 quarters. The position peaked at $130K in Q3 2015. 18 funds tracked by Wall St. Rank hold ETRM as of Q4 2016.

DAFNA Capital Management reported no remaining EnteroMedics Inc. position as of Q4 2016 after selling out during the quarter.
DAFNA Capital Management sold 476 EnteroMedics Inc. shares in Q4 2016, an estimated $5K.
DAFNA Capital Management first reported a position in EnteroMedics Inc. in Q3 2015 and held it in 5 quarters.
DAFNA Capital Management's EnteroMedics Inc. position peaked at $130K in Q3 2015.
18 funds tracked by Wall St. Rank held EnteroMedics Inc. as of Q4 2016.

Based on DAFNA Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.